B Parschalk
Overview
Explore the profile of B Parschalk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Presterl E, Lassnigg A, Parschalk B, Yassin F, Adametz H, Graninger W
Int J Artif Organs
. 2005 Dec;
28(11):1110-8.
PMID: 16353117
Unlabelled: Surgical implants and other foreign material are increasingly used in modern medicine to restore or to improve the function of the human body. Infection of an implant is associated...
2.
Heger M, Bergler-Klein J, Zehetgruber M, Parschalk B, Thalhammer F, Maurer G, et al.
Z Kardiol
. 2003 Oct;
92(8):677-81.
PMID: 14579845
Churg-Strauss syndrome is a rare disorder characterized by hypereosinophilia and a systemic vasculitis occurring inpatients with asthma and allergic rhinitis. Vasculitis commonly affects the lungs, the heart, the skin, and...
3.
Wenisch C, Werkgartner T, H. Sailer , Patruta S, Krause R, Daxboeck F, et al.
Eur J Clin Invest
. 2000 May;
30(5):460-6.
PMID: 10809907
Background: Cancer surgery is known to lead to a deterioration in host defence mechanisms and an increase in susceptibility to infection after operation. Filgrastim enhances important antimicrobial functions of neutrophils...
4.
Parschalk B
Curr Opin Urol
. 2000 Mar;
9(1):51-5.
PMID: 10726072
Post-exposure prevention is a combined modality approach to reducing HIV transmission. The recommendations are based on the risk of local prevalence and on the likelihood of transmission. In the light...
5.
Redlich K, Parschalk B, Ehringer H, Minar E
Vasa
. 1999 Dec;
28(4):301-3.
PMID: 10611851
Ticlopidine is increasingly used in the secondary prophylaxis in patients with arterial occlusive diseases. Neutropenia is a well known side effect of this drug. We report a case of a...
6.
Schindler K, Parschalk B, Schindl A, Wunderer K, Elmadfa I, Tschachler E, et al.
AIDS
. 1999 Dec;
13(17):2389-96.
PMID: 10597780
Objectives: (i) To investigate whether protease inhibitor (PI) (nelfinavir)-containing highly active antiretroviral therapy (HAART) affects body composition differently in HIV-infected and AIDS patients without wasting syndrome. (ii) To delineate the...
7.
Wenisch C, Parschalk B, Patruta S, Brustbauer R, Graninger W
Infection
. 1999 Jun;
27(3):183-6.
PMID: 10378129
The effect of immunoglobulin (Ig) preparations on neutrophil phagocytic ability and oxidative burst in response to Escherichia coli stimulation was analyzed in 14 patients with gram-negative septicemia by an ex...
8.
Lukas J, Egger S, Parschalk B, Stur M
Br J Ophthalmol
. 1999 Jan;
82(10):1217-8.
PMID: 9924316
No abstract available.
9.
Wenisch C, Looareesuwan S, Wilairatana P, Parschalk B, Vannapann S, Wanaratana V, et al.
Am J Trop Med Hyg
. 1998 Apr;
58(3):343-7.
PMID: 9546416
The effect of pentoxifylline (PTX) was tested for its capacity to modulate cytokine responses during therapy of severe Plasmodium falciparum malaria in a placebo-controlled, randomized study in 45 adult patients...
10.
Wenisch C, Spitzauer S, Rumpold H, Vannaphan S, Parschalk B, Graninger W, et al.
Clin Immunol Immunopathol
. 1997 Nov;
85(2):166-71.
PMID: 9344699
We determined indices of plasma complement activation (C3, C4, Bb, C4d, iC3b, and SC5b-9), levels of tumor necrosis factor (TNF) and interleukin-6, and the APACHE II score in 23 patients...